Dare Bioscience Investor Presentation Deck

Meta-analysis of 95 studies from 2000-2014 indicated prevalence of Female Sexual Dysfunction in premenopausal women worldwide is 41%, and difficulty with arousal alone is 23%.¹ Market research estimates: FSAD - What is the incidence? 33% of US women aged 21 to 60 (~20 million women), experience symptoms of low or no sexual arousal. ²,3 10 million women are considered distressed and actively seeking treatment. ² 1.McCool et al. Sex Med Rev 2016;4:197-212. 2.Ad Hoc Market Research: FSAD Prevalence Report (Oct 2015) conducted for SST LLC. 3.Based on US Census projections for 2016. 32

View entire presentation